STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $11,000 | -86.1% | 5,188 | -80.4% | 0.00% | – |
Q2 2021 | $79,000 | +75.6% | 26,449 | +63.2% | 0.00% | – |
Q1 2021 | $45,000 | -2.2% | 16,206 | -16.0% | 0.00% | – |
Q4 2020 | $46,000 | +360.0% | 19,300 | +309.8% | 0.00% | – |
Q3 2020 | $10,000 | -84.1% | 4,710 | -71.4% | 0.00% | – |
Q2 2020 | $63,000 | +34.0% | 16,488 | -34.2% | 0.00% | – |
Q1 2020 | $47,000 | -53.9% | 25,041 | -48.9% | 0.00% | – |
Q4 2019 | $102,000 | +72.9% | 49,027 | +99.8% | 0.00% | – |
Q3 2019 | $59,000 | +391.7% | 24,541 | +563.3% | 0.00% | – |
Q2 2019 | $12,000 | -42.9% | 3,700 | -12.0% | 0.00% | – |
Q1 2019 | $21,000 | +90.9% | 4,203 | +79.2% | 0.00% | – |
Q4 2018 | $11,000 | +450.0% | 2,345 | +422.3% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 449 | +70.1% | 0.00% | – |
Q4 2017 | $2,000 | -90.0% | 264 | -90.7% | 0.00% | – |
Q3 2017 | $20,000 | +400.0% | 2,840 | +278.2% | 0.00% | – |
Q3 2016 | $4,000 | -50.0% | 751 | -63.8% | 0.00% | – |
Q2 2016 | $8,000 | -42.9% | 2,077 | -30.0% | 0.00% | – |
Q1 2016 | $14,000 | -36.4% | 2,969 | +1.6% | 0.00% | – |
Q4 2015 | $22,000 | – | 2,923 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |